What CMPI does

CMPI (Center for Medicine in the Public Interest) is a nonprofit, nonpartisan research and educational organization founded in 2009 in New York, focused on advancing patient-centered healthcare policy. Its mission is to promote medicine that is more preventive, predictive, and personalized, with a thematic focus on FDA regulation, drug pricing, pharmaceutical supply chains, hospital billing practices, and comparative effectiveness research. The organization produces policy reports, white papers, op-eds, and the Drugwonks blog, and convenes stakeholders through events such as the annual Odyssey Gala, Capitol Hill briefings, and topical summits (e.g., the 3D Printing Summit). It has a Paris office in addition to its New York headquarters, indicating some international reach.

CMPI does not develop or sell technology products; its "deliverables" are thought leadership content and event programming. The go-to-market model is event- and content-driven: it reaches policymakers, healthcare professionals, media, and patient advocates through earned media (CNBC, Fox Business, Bloomberg, CNN), social channels, congressional testimony, and direct briefings. Revenue comes from donations and corporate sponsorships drawn primarily from the pharmaceutical and biotechnology industries, including major donors such as AbbVie, Pfizer, Bristol Myers Squibb, Merck, Gilead Sciences, GSK, Novo Nordisk, PhRMA, BIO, and the Lilly Foundation. Leadership is anchored by co-founders Peter J. Pitts (President; former FDA Associate Commissioner) and Robert M. Goldberg (Vice President), supported by a Board of Directors and Senior Fellows drawn from academia, medicine, and policy.

Name

CMPI

Legal name

Center for Medicine in the Public Interest

Website

https://cmpi.org

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

CMPI is a nonprofit, nonpartisan healthcare policy think tank founded in 2009 that produces research, commentary, and events to advance patient-centered medicine, funded primarily by pharmaceutical industry sponsors.

Ownership category

akta.pro rank

Product category

Healthcare Policy Research

akta.pro primary industry

Healthcare & Life Sciences PR (MPAAADAD)

Keywords

• Healthcare policy research
• Patient-centered medicine
• Pharmaceutical policy analysis
• FDA regulatory commentary
• Healthcare reform advocacy

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Donations and Sponsorships: CMPI is funded by donations and sponsorships from pharmaceutical companies, biotech firms, foundations, and other organizations in the healthcare sector. Major corporate sponsors include AbbVie, Pfizer, Bristol Myers Squibb, GSK, Gilead Sciences, Merck, Novo Nordisk, PhRMA, BIO, and others.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

The Center for Medicine in the Public Interest (CMPI) is a nonprofit, nonpartisan research and educational organization that produces healthcare policy research, white papers, reports, and educational events. It also maintains the Drugwonks blog, publishes commentary, hosts summits, galas and congressional briefings, and provides expert media commentary on FDA regulation, drug pricing, personalized medicine, biosimilars, and healthcare reform. CMPI does not sell commercial products; its offerings are research, educational content, and convening activities funded by donations and sponsorships.

Product overview

CMPI (Center for Medicine in the Public Interest) is a nonprofit, nonpartisan research and educational organization focused on healthcare policy research and advocacy, not a technology product company. It does not offer software products, platforms, or modules. Its outputs consist of policy research reports, commentary, events/conferences, videos, audio content, and educational resources on healthcare topics including FDA policy, drug pricing, personalized medicine, and hospital billing reform.

Differentiator

Problem solved

Functional benefit

Products and services

• Critical Path Project CMPI initiative conducted in cooperation with the Critical Path Institute to advance drug safety and regulatory science. It targets healthcare policy stakeholders, regulators, and pharmaceutical industry participants engaged in FDA regulatory science.
• Patient-Centric Prospective Medicine Project CMPI research program on patient-centric, prospective, and personalized medicine, with prior collaboration with Intermune on idiopathic pulmonary fibrosis research. It is intended for healthcare professionals, patient advocates, and policy researchers.
• Drugwonks Blog Editorial blog providing commentary on the pharmaceutical industry, FDA policy, drug pricing, PBMs, and healthcare reform. Targeted at healthcare professionals, policymakers, journalists, and the informed public.
• Policy Events and Convenings (Odyssey Gala, 3D Printing Summit, Capitol Hill Briefings) Educational and policy convenings including the annual Odyssey Gala honoring healthcare leaders, the 3D Printing Summit, Capitol Hill Briefings, and policy forums. Designed for policymakers, healthcare professionals, and industry stakeholders.
• Policy Research Reports and White Papers Published research reports, white papers, and policy analysis on healthcare topics including FDA regulation, drug pricing, hospital billing practices, biosimilars, and pharmaceutical supply chain policy. Targeted at policymakers, regulators, media, and healthcare professionals.

Quantifiable outcome

• Hundreds of published reports and articles on healthcare policy topics
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• Critical Path InstitutecoreStrategic or Co-development PartnerCMPI cooperates with the Critical Path Institute on activities advancing the Critical Path Initiative for drug safety and regulatory science.
• IntermunecoreStrategic or Co-development PartnerBiotechnology company that supported CMPI's Patient-Centric and Prospective Medicine Project research program on idiopathic pulmonary fibrosis.
• Johns Hopkins Bloomberg School of Public HealthcoreStrategic or Co-development PartnerDr. John F P Bridges, Associate Professor at Johns Hopkins, serves as principal investigator and Senior Fellow at CMPI.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• American Enterprise Institute (AEI): Large established think tank with a significant health policy program covering FDA, drug pricing, and healthcare reform. Operates as a broader institution but competes in the same healthcare commentary space as CMPI.
• Brookings Institution: Major policy research institution with an extensive health policy center producing research and hosting events on FDA, drug pricing, and healthcare reform — adjacent to CMPI's policy commentary work.
• Milken Institute: Nonprofit economic think tank whose FasterCures and health programs publish widely on biomedical innovation, drug pricing, and public health — overlapping with CMPI's research and convening activities.
• Hoover Institution: Stanford-based public policy research center with health policy work on FDA, drug development, and healthcare reform. Operates at a larger scale but addresses many of the same policy topics as CMPI.

Direct peers

• Kaiser Family Foundation (KFF): A leading nonprofit health policy research organization producing analysis, polling, and journalism on healthcare, mirroring CMPI's role as a nonpartisan policy research voice serving policymakers and the public.
• Manhattan Institute: Policy think tank where co-founder Robert M. Goldberg previously led the Center for Medical Progress. Comparable to CMPI as a center-right policy shop with active healthcare and pharmaceutical policy work.
• Galen Institute: Nonprofit health policy research organization focused on personalized medicine, patient-centered care, and biomedical innovation — overlapping thematically with CMPI's preventive, predictive, and personalized medicine focus.
• Pacific Research Institute: Free-market policy think tank with a long-standing focus on healthcare, pharmaceuticals, and FDA policy; directly comparable to CMPI in mission, ideological orientation, and donor-supported research model.
• The Commonwealth Fund: Private foundation focused on healthcare policy research and promoting a high-performing healthcare system; comparable to CMPI in mission, donor-funded model, and policy analysis output.

Others

• PhRMA (Pharmaceutical Research and Manufacturers of America): Major pharmaceutical industry trade association and CMPI donor. Comparable as a healthcare policy stakeholder, though PhRMA is an industry advocacy body rather than an independent think tank; useful benchmark for industry-aligned policy positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/drugwonks
• YouTubeyoutube.com/user/CMPIvideos
• Facebookfacebook.com/The-Center-for-Medicine-in-the-Public-Interest-153160158058393
• LinkedInlinkedin.com/in/drugwonks

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CMPI